Trans-catheter Aortic Valve Implantation

3

Review clinical trials related to Trans-catheter Aortic Valve Implantation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparative Observational Study of Supra-annular Versus Intra-annular Self-expanding Aortic Valves in Routine Clinical Practice

We proposed to compare in an observational study procedural success at one month (VARC 3 criteria) and clinical and echographic follow-up at 6 months between 2 self expandable devices in TAVR : the supra annular Evolut device (Medtronic) vs the intra anular NAVITOR device (Abott)

Participants needed: 419
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, MontpellierUpdated: Apr 1, 2026Locations: 1Duration: 36 Months
Eligibility criteria

all patients elligible for TAVR witn a self expandable device

femoral access not suitable [+1]

Status: Recruiting

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

The goal of this clinical trial is to evaluate the feasibility, effectiveness, and safety of pre-emptive left atrial veno-arterial extracorporeal membrane oxygenation (LAVA-ECMO) in patients undergoing complex and high-risk transcatheter aortic valve replacement (TAVR). These patients include adults with severe aortic stenosis who are hemodynamically unstable or at risk of instability due to anatomical complexity. The main questions it aims to answer are: 1. Does pre-emptive LAVA-ECMO reduce the incidence of in-hospital death, intraprocedural cardiac arrest, or emergent cardiac surgery? 2. What are the safety outcomes related to LAVA-ECMO, including major vascular, bleeding, or cardiac structural complications? -This is a single-arm, prospective, multi-center study with no comparison group. Participants will: * Be screened for eligibility based on hemodynamic status and anatomical complexity * Undergo pre-emptive LAVA-ECMO cannulation prior to or during TAVR * Receive follow-up assessments at 30 days and 1 year, including clinical evaluation and echocardiography

Participants needed: 30
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Atlantic Health SystemUpdated: Dec 30, 2025Locations: 2Duration: 30 Days
Eligibility criteria

Hemodynamic Criteria [+19]

Age <18 or pregnant [+10]

Status: Not yet recruiting

Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+

Purpose of the Study The purpose of this study is to investigate how a transcatheter aortic valve (TAVI, biological valve prosthesis) can best be positioned in order to avoid blockage of the coronary arteries by the valve material after implantation. Method The study will include patients undergoing TAVI. Participants will be randomized, meaning that it will be determined by chance which of two established implantation techniques is used. Both techniques are already part of routine clinical practice. Examinations After the procedure, a CT scan will be performed to evaluate the position of the valve in relation to the coronary arteries. This CT scan is the only additional examination beyond today's standard clinical practice. Significance If one of the techniques proves to provide better positioning of the valve, this method may be recommended as standard practice in future treatment. The study will therefore contribute to improved patient safety and treatment quality, as well as increase knowledge about optimal positioning and implantation techniques in TAVI.

Participants needed: 40
Trial details
Biological sex: AllType: InterventionalSponsor: Oslo University HospitalUpdated: Oct 16, 2025
Eligibility criteria

Patients with severe aortic stenosis indicated for TAVI after heart team meeting... [+3]

Severe peripheral vascular disease preventing transfemoral access. [+2]